ADVB ADVANCED BIOMED INC

Ownership history in CITADEL ADVISORS LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which CITADEL ADVISORS LLC reported a position in ADVANCED BIOMED INC (ADVB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 139,511 +81,843 +141.9% 0.00% $63K $8.96
2025 Q2 ADDED 57,668 +46,455 +414.3% 0.00% $40K $14.00
2025 Q1 INITIATED 11,213 0.00% $45K $78.40
% of Fund (quarterly)    ADVB price (monthly, adj. close)

Other funds also holding ADVB

As of 2025 Q4 — sorted by position size

XTX Topco Ltd 3Y 0.0% Virtu Financial LLC 3Y 7Y 0.0% UBS Group AG 3Y 7Y 0.0%
← Back to CITADEL ADVISORS LLC Holdings